Founder pay is an SR&ED input before it is a tax outcome
Salary paid to a founder doing eligible development is a qualified SR&ED expenditure, and under the proxy method it also drives the overhead add-on. A dividend is neither: it is a distribution, not spending, and it contributes nothing to the claim. In an R&D-heavy year, a founder who draws 80,000 dollars as dividends instead of salary has quietly shrunk the largest non-dilutive cheque available to the company.
The rules do police the obvious response. A founder holding 10% or more of any class is a specified employee: bonuses to them are excluded from the claim, and their claimable salary is capped at five times the year's maximum pensionable earnings. So the plan is not maximum salary, it is deliberate salary, set with the claim, RRSP room and CPP in view at once. That is standing work inside Tax Planning & Advisory, revisited whenever the company's stage changes.
What fits before a raise rarely fits after one
| Stage | Founder pay that usually fits |
|---|---|
| Bootstrapping, pre-revenue | Modest salary sized to living costs; every eligible dollar feeds the claim |
| After a SAFE round | Salary on real payroll, at a level the next lead investor will not question |
| After a priced round | Board-approved salary; dividends are usually off the table by covenant and by cap table |
| Approaching profitability | The salary and dividend blend becomes a live question for the first time |
| Approaching an exit | Compensation takes a back seat to keeping shares exemption-eligible |
Dividends tempt founders by skipping payroll paperwork, but a pre-profit CCPC has no earnings behind them, and once outside investors hold shares, distributions stop being a private choice. Payroll is not bureaucracy at that point; it is the only channel left, and it is the one diligence expects to see.
CCPC status can be signed away in a financing document
Control is the test. If non-residents or public corporations come to control the corporation, CCPC status ends, and the enhanced refundable SR&ED rate and the CCPC option treatment go with it. The trap is that rights count: an option or conversion right that would hand a non-resident investor control can be treated for these tests as if it had been exercised, so status can be lost on paper while the cap table still looks Canadian.
We read term sheets, side letters and shareholder agreements for exactly this before signature, because a redline is cheap and a repair is not. Where a structure has already drifted, Corporate Restructuring is the recovery path, but recovering after a signed round is the expensive version of catching it the week before.
Options are pay you are not writing cheques for, protect their treatment
A cash-poor startup pays its first ten hires partly in options, and CCPC options carry treatment those hires can feel: no taxable benefit at exercise, tax deferred until the employee actually sells the shares, the option deduction available on standard conditions, and the annual cap that limits the deduction at other employers does not apply to CCPC grants. Lose the status and new grants revert to tax at exercise, which candidates comparing offers will notice.
Housekeeping keeps the treatment real: a written plan, board-approved grants with an exercise price defensible against the share value on the grant date, and an option register that agrees with the minute book. When a plan is first drafted, we also model the grant sizes against the pool and the next round's dilution, so the promise made in an offer letter still makes sense on the post-money cap table.
The exemption clock rewards founders who start it early
A sale of qualifying small business corporation shares can shelter up to 1.25 million dollars of gain per founder under the lifetime capital gains exemption. The tests look backward: the shares must generally be held for 24 months, and the corporation's assets must stay predominantly in active business use through that window and at the sale itself. Success is the usual spoiler, because a large SR&ED refund or an undeployed raise sitting as idle cash can tip the asset tests offside.
The plan is boring and effective: review the balance sheet composition annually, keep surplus cash working or move it deliberately, and keep the corporate tax filings consistent with the exit story so nothing is a surprise the month an acquirer calls. We run this as a standing review for founders across Mississauga and the GTA, scoped in writing after a free 15-minute discovery call.
